Hyperthermic therapy for human neoplasms: Thermal death time
نویسندگان
چکیده
منابع مشابه
Induction of cell death in a glioblastoma line by hyperthermic therapy based on gold nanorods
BACKGROUND Metallic nanorods are promising agents for a wide range of biomedical applications. In this study, we developed an optical hyperthermia method capable of inducing in vitro death of glioblastoma cells. METHODS The procedure used was based on irradiation of gold nanorods with a continuous wave laser. This kind of nanoparticle converts absorbed light into localized heat within a short...
متن کاملInduction of cell death in a glioblastoma line by hyperthermic therapy based on gold nanorods
Correspondence: Milagros Ramos Gomez Centro de Tecnología Biomédica, Parque Científico y Tecnológico de la Universidad Politecnica de Madrid, Campus de Montegancedo, 28223 Pozuelo de Alarcón, Madrid, Spain Tel +34 91 336 4651 Fax +34 91 336 6828 Email [email protected] Background: Metallic nanorods are promising agents for a wide range of biomedical applications. In this study, we devel...
متن کاملTherapy-related myeloid neoplasms.
Session 5 of 2007 Workshop of the Society for Hematopathology/European Association for Haematopathology focused on therapy-related myeloid neoplasms. This report discusses the diversity and relevance of clinical, pathologic, and genetic features and provides an update on the pathogenesis of these disorders. We highlight common diagnostic issues such as the differentiation between therapy-relate...
متن کاملTherapy - related myeloid neoplasms
Professor Eliane Gluckman is Past Head of the Hematology Bone Marrow Transplantation Unit, Hospital Saint Louis, Paris and currently Professor Emeritus of University Paris VII, Director of Eurocord, and President of the European School of Haematology. Dr. Vanderson Rocha is Scientific Director of Eurocord, Chair of the Acute Leukemia Working Party of EBMT and medical assistant of the HSCT unit ...
متن کاملTherapy-Related Myeloid Neoplasms
Hodgkin lymphoma (HL) is a malignancy of the lymphatic system with an incidence of 2 3/100.000/year in developed countries. With modern multi optionally combined with radiotherapy (RT), 80% to 90% of HL patients achieve long remission and can be considered cured. However, current standard approaches bear a considerable risk for the development of treatment research in HL is reducing the inciden...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Cancer
سال: 1980
ISSN: 0008-543X,1097-0142
DOI: 10.1002/1097-0142(19801015)46:8<1849::aid-cncr2820460824>3.0.co;2-s